Objective To investigate the association between serum levels of fractalkine(FKN),follistatin-like protein 1(FSTL1),and mammalian sterile 20-like kinase 1(Mst1)and the severity of coronary artery stenosis(CAS),oxida-tive stress,and prognosis in patients with coronary heart disease(CHD).Methods Between January 2024 and January 2025,204 patients with CHD admitted to the Department of Cardiology at the Fourth Affiliated Hospital of Nanjing Medical Univer-sity were enrolled as the case group.Based on the Gensini score,patients were divided into a mild subgroup(77 cases),a moderate subgroup(69 cases),and a severe subgroup(58 cases).Based on prognosis,patients were further divided into a fa-vorable prognosis subgroup(152 cases)and an unfavorable prognosis subgroup(52 cases).Additionally,105 individuals who underwent health check-ups during the same period were selected as the healthy control group.Serum levels of FKN,FSTL1,and Mst1 were measured by ELISA.Correlation analysis was performed to examine the relationships between serum FKN,FSTL1,and Mst1 levels and the severity of CAS.Multivariate LASSO-logistic regression analysis was used to identify factors associated with unfavorable prognosis in CHD patients.ROC curves were constructed to evaluate the predictive value of serum FKN,FSTL1,and Mst1 individually and in combination for unfavorable prognosis.Results Serum levels of FKN,FSTL1,and Mst1 were significantly higher in the case group than in the healthy control group(t/P=58.392/<0.001,43.048/<0.001,45.009/<0.001).Serum FKN,FSTL1,Mst1,and MDA levels progressively increased across the mild,moderate,and severe subgroups,while SOD and GSH-Px levels progressively decreased(F/P=43.568/<0.001,31.507/<0.001,80.499/<0.001,69.392/<0.001,41.234/<0.001,59.089/<0.001).Serum FKN,FSTL1,and Mst1 levels were positively correlated with the se-verity of CAS(r/P=0.498/<0.001,0.536/<0.001,0.461/<0.001).Serum FKN,FSTL1,and Mst1 were positively correlated with MDA(r/P=0.397/<0.001,0.453/<0.001,0.409/<0.001)and negatively correlated with SOD and GSH-Px(FKN:r/P=-0.436/<0.001,-0.411/<0.001;FSTL1:-0.417/<0.001,-0.328/<0.001;Mst1:-0.354/<0.001,-0.442/<0.001).The un-favorable prognosis subgroup had significantly higher proportions of patients with multiple lesions,as well as higher FKN,FSTL1,Mst1,Gensini scores,CK-MB,cTnI,and MDA levels,while SOD and GSH-Px levels were significantly lower com-pared with the favorable prognosis subgroup(χ2/t/P=14.794/<0.001,8.235/<0.001,8.052/<0.001,8.821/<0.001,28.000/<0.001,5.304/<0.001,5.731/<0.001,7.849/<0.001,7.418/<0.001,7.817/<0.001).Multiple lesions,elevated Gensini score,ele-vated FKN,elevated FSTL1,and elevated Mst1 were independent risk factors for poor prognosis in CHD patients[OR(95%CI)=2.794(1.215-6.427),3.758(2.320-6.086),3.198(1.715-5.964),3.015(1.545-5.882),3.364(1.955-5.790)].The AUCs for serum FKN,FSTL1,Mst1 alone,and their combination for predicting poor prognosis were 0.813,0.813,0.828,and 0.934,respectively.The combined AUC was significantly higher than that of any single marker(Z/P=4.018/<0.001,3.192/<0.001,3.713/<0.001).Conclusion Elevated serum levels of FKN,FSTL1,and Mst1 in CHD patients are associated with the severity of coronary artery stenosis,oxidative stress,and prognosis.The combination of these three markers may serve as a potential biomarker for predicting poor prognosis in patients with CHD.